Cytokines in tumour growth, migration and metastasis

World Journal of Urology

Volumn 14, Issue 3, 1996, Pages 157-165

  Negus, R P M ^a   Balkwill, F R ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL; CELL MOTION; HUMAN; METASTASIS; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL MOVEMENT; CYTOKINES; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 0029683281     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00186895     Document Type: Article

References (134)

1. Arrick B A, Lopez AR, Elfman F, Ebner R, Damsky CH, Derynck R (1992) Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1. J Cell Biol 118: 715-726
2. Aznavoorian S, Murphy AN, Steiler Stevenson WG, Liotta LA ( 1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71 : 1368-1383
3. Baserga R, Rubin R (1993) Cell cycle and growth control. CRC Crit Rev Euk Gene Expr 3:47-61
4. Basson MD, Modlin IM, Madri JA (1992) Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest 90:15-23
5. Berkman RA, Merrill MJ. Reinhold WC, Monacci WT. Saxena A, Clark WC Robertson JT, Ali RJ, Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153-159
6. Bolufer P, Miralles F, Rodriguez A, Vazquez C, Lluch A. Garcia Conde J, Olmos T (I990) Epidermal growth factor receptor in human breast cancer: correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics. Eur J Cancer 26:283-290
7. Boocock ÇA (I995) Expression of vascular endothelial growthfactor and its receptors fit and kdr in ovarian-carcinoma. J Natl Cancer Inst 87:506-516
8. Breillout F, Antoine E, Lascaux V, Rolland Y, Poupon MF (1989) Promotion of micrometastasis proliferation in a rat rhabdomyosarcoma model by epidermal growth factor. J Natl Cancer Inst 81:702-705
9. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255-1262
10. Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101
11. Carpenter G, Cohen S (1990) Epidermal growth factor. J Biol Chem 265:7709-7712
12. Cavaillon JM (1994) Cytokines and macrophages. Biomed Pharmacother 48:445-453
13. Clark SC, Kamen R (1987) The human hematopoietic colonystimulating factors. Science 236:1229-1237
14. Clemmons DR, Shaw DS (1983) Variables controlling somatomedin production by cultured human fibroblasts. J Cell Physiol 115:137-142
15. Cochran BH, Reffel AC, Stiles CD (1983) Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33:939-947
16. Colletti RB, Roberts JD, Devlin JT, Copeland KC (1989) Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 49:1882-1884
17. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584
18. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR (1993) Activity of type IV collagneases in benign and malignant breast disease. Br J Cancer 67:1126-1131
19. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365-5369
20. Derynck R (1988) Transforming growth factor alpha. Cell 54: 593-595
21. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712
22. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L. Senger DR (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 174: 1275-1278
23. Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo KT, Yeo TK, Dvorak AM, Water L van de, Sioussat TM, Senger DR (1992) Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann NY Acad Sci 667: 101-111
24. Dvorak HJ. Brown LF, Detmar M, Dvorak AM (1995) Vascular-permeability factor vascular endothelial growth-factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
25. El Badry OM, Minniti C, Kohn EC, Houghton PJ, Daughaday WH, Helman LJ (1990) Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1:325-331
26. Elson SD, Browne CA, Thorburn GD (1984) Identification of epidermal growth factor-like activity in human male reproductive tissues and fluids. J Clin Endocrinol Metab 58:589594
27. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guilemin R (1985) Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82: 6507-6511
28. Feldkamper M, Enderle Sehmitt U, Hackenberg R, Schulz KD (1994) Urinary excretion of growth factors in patients with ovarian cancer. Eur J Cancer 12: 1851-1858
29. Fidler IJ (1985) Macrophages and metastasis - a biolological approach to cancer therapy. Caneer Res 45:4714-4726
30. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31
31. Folkman J, Klagsburn M (1987) Angiogenic factors. Science 235:442-447
32. Fong CJ, Sherwood ER, Mendelsohn J, Lee C, Kozlowski JM (1992) Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor alpha. Cancer Res 52:5887-5892
33. Gimbrone MA Jr. Leapman SB, Cotran RS, Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261-276
34. Gospodarowicz D (1990) Fibroblast growth factor. Chemical structure and biologic function. Clin Orthop 257:231-248
35. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941
36. Grey AM, Schor AM, Rushton G, Ellis l, Schor SL (1989) Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 86:2438-2442
37. Haskill S, Becker S. Fowler W, Walton L (1982) Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br J Cancer 45 : 728-736
38. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 18061814
39. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037
40. Hoyhtya M, Fridman R, Komarek D, Porter Jordan K, Stetler Stevenson WG, Liotta LA, Liang CM (1994) Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 56:500-505
41. Husby G, Hoagland PM, Strickland RG, Williams RC Jr ( 1976) Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest 57: 1471-1482
42. Kacinski BM (1995) CSF-1 and its receptors in ovarian, endometrial and breast cancer. Ann Med 27:79-85
43. Kandel J, Bossy Wetzel E, Radvanyi F, Klagsbrun M, Folkman J. Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104
44. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and requirement of BSF2/1L-6 for human multiple myelomas. Nature 332:83-85
45. Keski Oja J, Lyons RM, Moses HL (1987) Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1. Cancer Res 47:64516458
46. Khazaie K, Schirrmacher V, Lichtner RB (1993) EOF receptor in neoplasia and metastasis. Cancer Metastsis Rev 12:255-274
47. Kirn KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
48. Kishimoto T, Hirano T (1988) Molecular regulation of B lymphocyte response. Annu Rev Immunol 6:485-512
49. Klijn JG, Berns PM, Schmilz PI, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev 13:3-17
50. Kohn EC, Hollister GH, Di Persio JD, Wahl S, Liotta LA, Schiffmann E (1993) Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer 53:968-972
51. Leibovich SJ, Polverini PJ, Shepard HM, Wisemen DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329: 630-632
52. Lemoine NR, Jain S, Silvestre F, Lopes C, Hughes CM, MceLelland E, Gullick WJ, Filipe MI (1991) Amplification and overexpression of the EOF receptor and c-erbB-2 protooncogenes in human stomach cancer. Br J Cancer 64:79-83
53. LeRoith D, Baserga R, Helman L, Roberts CT Jr (1995) Insulin-like growth factors and cancer. Ann Intern Med 122: 54-59
54. Lindmark G, Sundberg C, Glimelius B, Pahlman L, Rubin K, Gerdin B (1993) Stromal expression of platelet-derived growth beta-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab Invest 69:682-689
55. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77-79
56. Mantovani A (1994) Tumor-associated macrophages in néoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71:5-16
57. Mattel S. Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M ( 1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56:853-857
58. Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53:288-295
59. Maxwell M, Naber SP, Wolfe H, Galanopoulos T, Hedley Whyte ET, Black PM, Antoniades HN (1990) Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131-140
60. Maygarden SJ, Strom S, Ware JL (1992) Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116:269-273
61. Merlo A, Juretic A, Zuber M, Filgueira L, Luscher U, Caetano V, Ulrich J, Gratzl O, Heberer M, Spagnoli GC (1993) Cytokine gene expression in primary brain tumours, metas-tases and meningiomas suggests specific transcription patterns. EurJ Cancer 15:2118-2125
62. Millauer B, Shawver LK, Plate KH, Risau W. Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579
63. Miller MD, Krangel MS ( 1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. CRC Crit Rev Immunol 12: 17-46
64. Minniti CP, Tsokos M, Newton NW Jr, Helman LJ (1994) Specific expression of insulin-like growth factor-Il in rhabdomyosarcoma tumor cells. Am J Clin Pathol 101: 198-203
65. Miyazawa K, Tsubouchi H, Naka D, Takahashi K. Okigaki M. Arakaki N, Nakayama H, Hirono S. Sakiyama O, Takahashi K. Gohda E, Daikuhara Y, Kitamura N (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163:967-973
66. Nagy JA, Herzberg KT, Dvorak JM, Dvorak HF (1993) Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res 53:2631-2643
67. Nakamori S, Watanabe H, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Raz A (1994) Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer 74: 1855-1862
68. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113:981-986
69. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR (1993) Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91:2194-2206
70. Naylor MS, Stamp GW, Davies BD, Balkwill FR (1994) Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58:50-56
71. Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JR, Harris AL (1985) Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1:366-368
72. Negus RPM, Stamp GWH, Reif MG, Burke F, Malik STA, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill RF (1995) The detection and localisation of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391-2396
73. Newman MJ (1993) Transforming growth factor beta and the cell surface in tumor progression. Cancer Metastasis Rev 12: 239-254
74. Niesvizky R, Siegel D, Michaeli J (1993) Biology and treatment of multiple myeloma. Blood Rev 7:24-33
75. Nugent MA, Lane EA, Keski Oja J, Moses HL, Newman MJ (1989) Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta. Cancer Res 49:3884-3890
76. Oison TA, Mohanraj D, Carson LF, Ramakrishnan S (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54:276-280
77. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene intercrine cytokine family. Annu Rev Immunol 9:617-648
78. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of métastases by a Lewis lung carcinoma [see comments]. Cell 79:315-328
79. Otto T, Birchmeier W, Schmidt U, Hinke A, Schipper J, Rubben H, Raz A (1994) Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res 54: 3120-3123
80. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS, Germain MJ (1977) Identification and comparative analysis of thymidine phosphorylase in the plasma of healtyh subjects and cancer patients. J Natl Cancer Inst 58:1587-1590
81. Pertovaara L, Kaipainen A. Mustonen T. Orpana A. Ferrara N. SaksclaO, Alitalo K (1994) Vascular cndothclial growth t'aclor is induced in response to transforming growth factor-beta in fibrohlastic and epithelial cells. J Biol Chem 269:6271-6274
82. Pietrzkowski Z, Mulholland G, Cornelia L, Jameson BA. Wernicke D. Baserga R (1993) Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res 53: 1 102-1 106
83. Plait- KH. Breier G. Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogcnesis factor in human gliomas in vivo. Nature 359:845-848
84. Pollak MN, Polychronakos C. Richard M (1990) Insulin-like growth factor I: a potent mitogen for human osteogenic sarcoma. J Natl Cancer Inst 82:301-305
85. Ponten F, Ren Z, Nister M, Westermark B. Ponten J (1994) Epithelial-stromal interactions in basal cell cancer: the PDGF system. J Invest Dermatol 102:304-309
86. Porcu P. Ferber A, Pietrzkowski Z, Roberts CT, Adamo M. LeRoith D, Baserga R (1992) The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor 1 with its receptor. Mol Cell Biol 12: 5069-5077
87. Pusztai L, Clover LM, Cooper K, Starkey PM, Lewis CE. McGee JO ( 1994) Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 70:289-292
88. Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC Jr, Brown EL (1989) Constitutive production of marcophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 83:921-926
89. Ravenswaay Claasen HH van, Kluin PM, Fleuren GJ (1992) Tumor infiltrating cells in human cancer. On the possible role of CD 16+ macrophages in antitumor cytotoxicity. Lab Invest 67:166-174
90. Reed JA, McNutt NS, Prieto VG, Albino AP (1994) Expression of transforming growth factor beta-2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol 145:97-104
91. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R (1994) Association of ovarian malignancy with expression of plateletderived endothelial cell growth factor. J Natl Cancer Inst 86: 1234-1238
92. Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke U. Derynek R (1988) Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J 7:2025-2033
93. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB ( 1981 ) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78:5339-5343
94. Ross R, Raines EW. Bowen Pope DF (1986) The biology of platelet-derived growth factor. Cell 46:155-169
95. Sainsbury JR, Farndon JR, Needham GK, Malcolm A, Harris AL ( 1987) Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398-1402
96. Salomon DS, Perroteau I, Kidwell WR, Tarn J, Derynek R (1987) Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ra.v-transformed mouse mammary epithelial cells. J CellPhysiol 130:397-409
97. Santon JB, Cronin MT, MacLeod CL, Mendelsohn J, Masui H, Gill GN (1986) Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res 46:4701-4705
98. Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R (1994) Heparinase inhibits neovascularization. Proc Nat! Acad Sci USA 91:1524-1528
99. Scambia G, Benedetti Panici P, Battaglia F, Ferrandina G, Baiocchi G, Greggi S, De Vincenzo R, Mancuso S (1992) Significance of epidermal growth factor receptor in advanced ovarian cancer. J Clin Oncol 10:529-535
100. Scholl SM. Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L, Tang R, Pouillart P, Lidereau R (1994) Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86: 120-126
101. Sciacca FL, Sturzi M, Bussolino F. Sironi M, Brandsetter H, Zietz C. Zhou D. Matteucci C, Péri G, Sozzani S (1994) Expression of adhesion molecules, platelet-activating factor and chemokines by Kaposi's sarcoma cells. J Immunol 153:48164825
102. Seiki M, Sato H, Liotta LA, Schiffmann E (1991) Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells. Int J Cancer 49:717-720
103. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF (1990) Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50: 1774-1778
104. Senger DR, Van de Water L, Brown LF. Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW. Dvorak AM, Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastsis Rev 12:303-324
105. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin OR (1982) Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Biol 92:584-588
106. Sharpe RJ. Byers HR. Scott CF, Bauer SI, Maione TE (1990) Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848-853
107. Sherman ML, Weber BL, Datta R, Kufe DW (1990) Transcriptional and posttranscriptional regulation of macrophagespecific colony-stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabolites [published erratum appears in J Clin Invest (1990) 85:1338], J Clin Invest 85:442-447
108. Shweiki D, Itin A, Softer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
109. Srivastava A, Laidler P, Davies RP, Morgan K, Hughes LE ( 1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologie study. Am J Pathol 133:419-423
110. Stoker M, Gherardi E (1991) Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta 1072:81-102
111. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, Liotta LA (1992) Identification, purification, and partial sequence analysis of autotaxin, a novel motilitystimulating protein. J Biol Chem 267:2524-2529
112. Takeshima H, Kuratsu J. Takeya M, Yoshimura T, Ushio Y (1994) Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 80: 1056-1062
113. Tannock IF (1968) The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 22:258-273
114. Tannock IF (1970) Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. Cancer Res 30:2470-2476
115. Tcrman BL Dougher Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586
116. Thorne HJ, Jose DG. Zhang HY, Dempsey PJ, Whitehead RH (1987) Epidermal growth factor stimulates the synthesis of cell-attachment proteins in the human breast cancer cell line PMC42. Int J Cancer 40:207-212
117. 17. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61 :203-212
118. Ullrich A, Coussens L, Haytlick JS, Dull TJ, Gray A, Tarn AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELY, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425
119. Underwood JC (1974) Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer 30:538-548
120. Versnel MA, Haarbrink M, Langerak AW, Laat PA de, Hagemaijer A, Kwast TH van der, Berg Bakker LA van den, Schrier PI ( 1994) Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo. Cancer Genet Cytogenet 73:60-64
121. Vignaud JM, Marie B, Klein N, Plena! F. Pech M, Borrelly J, Martinet N, Duprez A, Martinet Y (1994) The role of plateletderived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res 54:5455-5463
122. Vries C de, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase. a receptor for vascular endothelial growth factor. Science 255:989-991
123. Wang M, Stearns M, Stearns ME (1994) Identification of the receptor for a novel M(r) 78,000 invasion stimulating factor from metastatic human prostatic PC-3 ML clones. Cancer Res 54:2492-2495
124. Wang Y, Seiden AC, Morgan N, Stamp GW, Hodgson HJ (1994) Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 144:675-682
125. Ware JL (1993) Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 12:287-301
126. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis -correlation in invasive breast carcinoma. N Engl J Med 324:1-8
127. Welch DR, Fabra A, Nakajima M (1990) Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87:7678-7682
128. Xu FJ, Ramakrishnan S, Daly L, Soper JT, Berchuck A. Clarke Pearson D, Bast RC Jr (1991) Increased serum levels of marcophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol 165 :1356-1362
129. Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M (1988) Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8:1816-1820
130. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N (1989) Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3: 509-517
131. Yee D, Morales FR, Hamilton TC, Von Hoff DD (1991) Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res 51:5107-5112
132. Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855865
133. Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D. Chiaffarino F, Abboud HE, Van Damme J, Mantovani A, Remuzzi G (1991) Interleukin-1-beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol 138:991-1003
134. Zumkeller W, Schwander J, Mitchell CD, Morrell DJ, Schofield PN, Preece MA (1993) Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms's tumour. Eur J Cancer 14: 1973-1977